COG-AGCT1531: A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Title
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Principal Investigator
Meyer, Ashley
Phase
III
Age Group
Both
Applicable Disease Sites
Other Cancers
Participating Institutions
Mary Babb Randolph Cancer Center
Contacts
Carla Corbin, RN, BSN
Nurse Clinician
Phone: +1 304-293-1217
Email:
April Shay, MSN, PNP-BC
Nurse Practitioner
Phone: +1 304-293-1217
Email:
Christy Glass, MSN
APRN
Phone: +1 304-598-4835
Email:
Ashley Kitzmiller, RN
Nurse Coordinator
Phone: +1 304-293-1217
Email:
Lily Kastelic, BS
Data Analyst
Email:

View on ClinicalTrials.gov